Highly motivated, versatile and result-oriented Scientist/Consultant/Subject Matter Expert with strong research background and exceptional publication record in cell and molecular biology, virology, oncology, immunology, immunotherapy, cell and gene therapy especially CAR-T cell therapy. Expertise in several in vitro, in vivo and ex vivo models across multiple therapeutic areas. Experience in all stages of life sciences product development - R&D, Preclinical and Clinical Development, Commercialization, Supply Chain Management, Sales and Marketing Possess excellent communication, presentation and interpersonal skills and the ability to collaborate successfully in cross-functional teams. Pragmatic strategist who understands an organization’s vision and goals and delivers accordingly. Currently working as Cell & Gene Therapy Domain Consultant at Hexaware Technologies. Part of a global team focused on building digital capabilities and optimizing business processes for our clients in order to commercialize and scale their Cell and Gene Therapies. Passionate about unlocking the true potential of cell and gene therapies by creating a CGT Value Chain that’s transparent, real-time, and patient-centric. Has thorough understanding of every step along the CGT value chain: • Clinical Site Selection, Onboarding and Execution • Apheresis Network Strategy • Patient Tracking and Monitoring • Manufacturing and QC Testing • Tracking Product Journey (COI/COC) Core specialties are: • Cell and Gene Therapy • Autologous and Allogeneic CAR-T cell therapy for hematological malignancies and solid tumors • CAR Design and Optimization • CAR-T Cell Manufacturing, Process Development and QC Testing • CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia • cGMP Production of Plasmids, LV and AAV • Small Molecule Drug Discovery (Cancer Immunotherapy) • Oncology/Immuno-Oncology • Agile Project Management using JIRA and KANBAN Passionate about helping pharmaceutical/biotech clients build R&D and Operations capabilities needed to drive innovation, improve productivity and performance, and develop successful portfolio and asset strategies.